<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36254462</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-4804</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>21</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>10</Day></PubDate></JournalIssue><Title>Journal of medicinal chemistry</Title><ISOAbbreviation>J Med Chem</ISOAbbreviation></Journal><ArticleTitle>Discovery and Optimization of Quinoline Analogues as Novel Potent Antivirals against Enterovirus D68.</ArticleTitle><Pagination><StartPage>14792</StartPage><EndPage>14808</EndPage><MedlinePgn>14792-14808</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.jmedchem.2c01311</ELocationID><Abstract><AbstractText>Enterovirus D68 (EV-D68) is a nonpolio enterovirus that is mainly transmitted through respiratory routes and poses a potential threat for large-scale spread. EV-D68 infections mostly cause moderate to severe respiratory diseases in children and potentially induce neurological diseases. However, there are no specific antiviral drugs or vaccines against EV-D68. Herein, through virtual screening and rational design, a series of novel quinoline analogues as anti-EV-D68 agents targeting VP1 were identified. Particularly, <b>19</b> exhibited potent antiviral activity with an EC<sub>50</sub> value ranging from 0.05 to 0.10 μM against various EV-D68 strains and showed inhibition of viral replication verified by Western blot, immunofluorescence, and plaque formation assay. Mechanistic studies indicated that the anti-EV-D68 agents work mainly by interacting with VP1. The acceptable bioavailability of 23.9% in rats and significant metabolic stability in human liver microsome (Cl<sub>int</sub> = 10.8 mL/min/kg, <i>t</i><sub>1/2</sub> = 148 min) indicated that compound <b>19</b> with a novel scaffold was worth further investigation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaoyuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuexiang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Shiyong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Ruiyuan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaojia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Xiaomeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Longfa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361102, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Tong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361102, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Honglin</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-2270-1900</Identifier><AffiliationInfo><Affiliation>Shanghai Key Laboratory of New Drug Design, State Key Laboratory of Bioreactor Engineering, School of Pharmacy, East China University of Science &amp; Technology, Shanghai 200237, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Wu</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-0536-620X</Identifier><AffiliationInfo><Affiliation>National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Chem</MedlineTA><NlmUniqueID>9716531</NlmUniqueID><ISSNLinking>0022-2623</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011804">Quinolines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="Y">Enterovirus D, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011804" MajorTopicYN="Y">Quinolines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors
declare no competing financial interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>3</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36254462</ArticleId><ArticleId IdType="pmc">PMC9661475</ArticleId><ArticleId IdType="doi">10.1021/acs.jmedchem.2c01311</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sun J.; Hu X. Y.; Yu X. F. Current Understanding of Human Enterovirus D68. Viruses 2019, 11, 490.10.3390/v11060490.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11060490</ArticleId><ArticleId IdType="pmc">PMC6631698</ArticleId><ArticleId IdType="pubmed">31146373</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassidy H.; Poelman R.; Knoester M.; Van Leer-Buter C. C.; Niesters H. G. M. Enterovirus D68 - The New Polio?. Front. Microbiol. 2018, 9, 2677.10.3389/fmicb.2018.02677.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.02677</ArticleId><ArticleId IdType="pmc">PMC6243117</ArticleId><ArticleId IdType="pubmed">30483226</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste M. S.; Maher K.; Schnurr D.; Flemister M. R.; Lovchik J. C.; Peters H.; Sessions W.; Kirk C.; Chatterjee N.; Fuller S.; Hanauer J. M.; Pallansch M. A. Enterovirus 68 is Associated with Respiratory Illness and Shares Biological Features with Both the Enteroviruses and the Rhinoviruses. J. Gen. Virol. 2004, 85, 2577–2584. 10.1099/vir.0.79925-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.79925-0</ArticleId><ArticleId IdType="pubmed">15302951</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura T.; Okamoto M.; Nakakita S.; Suzuki A.; Saito M.; Tamaki R.; Lupisan S.; Roy C. N.; Hiramatsu H.; Sugawara K. E.; Mizuta K.; Matsuzaki Y.; Suzuki Y.; Oshitani H. Antigenic and Receptor Binding Properties of Enterovirus 68. J. Virol. 2014, 88, 2374–2384. 10.1128/JVI.03070-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03070-13</ArticleId><ArticleId IdType="pmc">PMC3958110</ArticleId><ArticleId IdType="pubmed">24371050</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.; Sheng J.; Baggen J.; Meng G.; Xiao C.; Thibaut H. J.; Van Kuppeveld F. J.; Rossmann M. G. Sialic Acid-Dependent Cell Entry of Human Enterovirus D68. Nat. Commun. 2015, 6, 8865.10.1038/ncomms9865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms9865</ArticleId><ArticleId IdType="pmc">PMC4660200</ArticleId><ArticleId IdType="pubmed">26563423</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley C. M.; Watson J. T.; Nix W. A.; Curns A. T.; Rogers S. L.; Brown B. A.; Conover C.; Dominguez S. R.; Feikin D. R.; Gray S.; Hassan F.; Hoferka S.; Jackson M. A.; Johnson D.; Leshem E.; Miller L.; Nichols J. B.; Nyquist A. C.; Obringer E.; Patel A.; Patel M.; Rha B.; Schneider E.; Schuster J. E.; Selvarangan R.; Seward J. F.; Turabelidze G.; Oberste M. S.; Pallansch M. A.; Gerber S. I. Severe Respiratory Illness Associated with a Nationwide Outbreak of Enterovirus D68 in the USA (2014): A Descriptive Epidemiological Investigation. Lancet Respir. Med. 2015, 3, 879–887. 10.1016/S2213-2600(15)00335-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(15)00335-5</ArticleId><ArticleId IdType="pmc">PMC5693332</ArticleId><ArticleId IdType="pubmed">26482320</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J.; Thibaut H. J.; Strating J.; Van Kuppeveld F. J. M. The Life Cycle of Non-Polio Enteroviruses and How to Target It. Nat. Rev. Microbiol. 2018, 16, 368–381. 10.1038/s41579-018-0005-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm-Hansen C. C.; Midgley S. E.; Fischer T. K. Global Emergence of Enterovirus D68: A Systematic Review. Lancet Infect. Dis. 2016, 16, e64–e75. 10.1016/S1473-3099(15)00543-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)00543-5</ArticleId><ArticleId IdType="pubmed">26929196</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreuter J. D.; Barnes A.; McCarthy J. E.; Schwartzman J. D.; Oberste M. S.; Rhodes C. H.; Modlin J. F.; Wright P. F. A Fatal Central Nervous System Enterovirus 68 Infection. Arch. Pathol. Lab. Med. 2011, 135, 793–796. 10.5858/2010-0174-CR.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/2010-0174-CR.1</ArticleId><ArticleId IdType="pubmed">21631275</ArticleId></ArticleIdList></Reference><Reference><Citation>Poelman R.; Schuffenecker I.; Van Leer-Buter C.; Josset L.; Niesters H. G.; Lina B. European Surveillance for Enterovirus D68 during the Emerging North-American Outbreak in 2014. J. Clin. Virol. 2015, 71, 1–9. 10.1016/j.jcv.2015.07.296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.07.296</ArticleId><ArticleId IdType="pubmed">26364237</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S.; Bosis S.; Niesters H.; Principi N. Enterovirus D68 Infection. Viruses 2015, 7, 6043–6050. 10.3390/v7112925.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7112925</ArticleId><ArticleId IdType="pmc">PMC4664996</ArticleId><ArticleId IdType="pubmed">26610548</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K.; Schreiner T. L.; Maloney J. A.; Wallace A.; Ludke J.; Oberste M. S.; Nix W. A.; Robinson C. C.; Glodé M. P.; Abzug M. J.; Dominguez S. R. A Cluster of Acute Flaccid Paralysis and Cranial Nerve Dysfunction Temporally Associated with an Outbreak of Enterovirus D68 in Children in Colorado, USA. Lancet 2015, 385, 1662–1671. 10.1016/S0140-6736(14)62457-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)62457-0</ArticleId><ArticleId IdType="pubmed">25638662</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K.; Asturias E. J.; Hixon A. M.; Van Leer-Buter C.; Niesters H. G. M.; Tyler K. L.; Abzug M. J.; Dominguez S. R. Enterovirus D68 and Acute Flaccid Myelitis-Evaluating the Evidence for Causality. Lancet Infect. Dis. 2018, 18, e239–e247. 10.1016/S1473-3099(18)30094-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30094-X</ArticleId><ArticleId IdType="pmc">PMC6778404</ArticleId><ArticleId IdType="pubmed">29482893</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.; Sheng J.; Fokine A.; Meng G.; Shin W. H.; Long F.; Kuhn R. J.; Kihara D.; Rossmann M. G. Structure and Inhibition of EV-D68, a Virus that Causes Respiratory Illness in Children. Science 2015, 347, 71–74. 10.1126/science.1261962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1261962</ArticleId><ArticleId IdType="pmc">PMC4307789</ArticleId><ArticleId IdType="pubmed">25554786</ArticleId></ArticleIdList></Reference><Reference><Citation>Hixon A. M.; Frost J.; Rudy M. J.; Messacar K.; Clarke P.; Tyler K. L. Understanding Enterovirus D68-Induced Neurologic Disease: A Basic Science Review. Viruses 2019, 11, 821.10.3390/v11090821.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11090821</ArticleId><ArticleId IdType="pmc">PMC6783995</ArticleId><ArticleId IdType="pubmed">31487952</ArticleId></ArticleIdList></Reference><Reference><Citation>Opanda S. M.; Wamunyokoli F.; Khamadi S.; Coldren R.; Bulimo W. D. Genetic Diversity of Human Enterovirus 68 Strains Isolated in Kenya Using the Hypervariable 3′-End of VP1 Gene. PLoS One 2014, 9, e102866.10.1371/journal.pone.0102866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0102866</ArticleId><ArticleId IdType="pmc">PMC4108357</ArticleId><ArticleId IdType="pubmed">25054861</ArticleId></ArticleIdList></Reference><Reference><Citation>Egorova A.; Ekins S.; Schmidtke M.; Makarov V. Back to the Future: Advances in Development of Broad-Spectrum Capsid-Binding Inhibitors of Enteroviruses. Eur. J. Med. Chem. 2019, 178, 606–622. 10.1016/j.ejmech.2019.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2019.06.008</ArticleId><ArticleId IdType="pmc">PMC8194503</ArticleId><ArticleId IdType="pubmed">31226653</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossmann M. G.; He Y.; Kuhn R. J. Picornavirus-Receptor Interactions. Trends Microbiol. 2002, 10, 324–331. 10.1016/S0966-842X(02)02383-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0966-842X(02)02383-1</ArticleId><ArticleId IdType="pubmed">12110211</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma C.; Hu Y.; Zhang J.; Musharrafieh R.; Wang J. A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68. ACS Infect. Dis. 2019, 5, 1952–1962. 10.1021/acsinfecdis.9b00284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.9b00284</ArticleId><ArticleId IdType="pmc">PMC7167248</ArticleId><ArticleId IdType="pubmed">31532189</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnard D. L.; Hubbard V. D.; Smee D. F.; Sidwell R. W.; Watson K. G.; Tucker S. P.; Reece P. A. In Vitro Activity of Expanded-Spectrum Pyridazinyl Oxime Ethers Related to Pirodavir: Novel Capsid-Binding Inhibitors with Potent Antipicornavirus Activity. Antimicrob. Agents Chemother. 2004, 48, 1766–1772. 10.1128/AAC.48.5.1766-1772.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.48.5.1766-1772.2004</ArticleId><ArticleId IdType="pmc">PMC400527</ArticleId><ArticleId IdType="pubmed">15105133</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan H.; Hocutt F. M.; Jones T. K.; Rabinowitz M. H. A One-Step Synthesis of 2,4-Unsubstituted Quinoline-3-Carboxylic Acid Esters from O-Nitrobenzaldehydes. J. Org. Chem. 2010, 75, 3488–3491. 10.1021/jo100392x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jo100392x</ArticleId><ArticleId IdType="pubmed">20420395</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacroix C.; Laconi S.; Angius F.; Coluccia A.; Silvestri R.; Pompei R.; Neyts J.; Leyssen P. In Vitro Characterisation of a Pleconaril/Pirodavir-Like Compound with Potent Activity against Rhinoviruses. Virol. J. 2015, 12, 106.10.1186/s12985-015-0330-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-015-0330-4</ArticleId><ArticleId IdType="pmc">PMC4501209</ArticleId><ArticleId IdType="pubmed">26169596</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J.; Wang X.; Hu Z.; Gao Q.; Sun Y.; Li X.; Porta C.; Walter T. S.; Gilbert R. J.; Zhao Y.; Axford D.; Williams M.; McAuley K.; Rowlands D. J.; Yin W.; Wang J.; Stuart D. I.; Rao Z.; Fry E. E. Picornavirus Uncoating Intermediate Captured in Atomic Detail. Nat. Commun. 2013, 4, 1929.10.1038/ncomms2889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2889</ArticleId><ArticleId IdType="pmc">PMC3709478</ArticleId><ArticleId IdType="pubmed">23728514</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X.; Peng W.; Ren J.; Hu Z.; Xu J.; Lou Z.; Li X.; Yin W.; Shen X.; Porta C.; Walter T. S.; Evans G.; Axford D.; Owen R.; Rowlands D. J.; Wang J.; Stuart D. I.; Fry E. E.; Rao Z. A Sensor-Adaptor Mechanism for Enterovirus Uncoating from Structures of EV71. Nat. Struct. Mol. Biol. 2012, 19, 424–429. 10.1038/nsmb.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2255</ArticleId><ArticleId IdType="pmc">PMC3378640</ArticleId><ArticleId IdType="pubmed">22388738</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter T. S.; Ren J.; Tuthill T. J.; Rowlands D. J.; Stuart D. I.; Fry E. E. A Plate-Based High-Throughput Assay for Virus Stability and Vaccine Formulation. J. Virol. Methods 2012, 185, 166–170. 10.1016/j.jviromet.2012.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2012.06.014</ArticleId><ArticleId IdType="pmc">PMC3470038</ArticleId><ArticleId IdType="pubmed">22744000</ArticleId></ArticleIdList></Reference><Reference><Citation>De Colibus L.; Wang X.; Spyrou J. A. B.; Kelly J.; Ren J.; Grimes J.; Puerstinger G.; Stonehouse N.; Walter T. S.; Hu Z.; Wang J.; Li X.; Peng W.; Rowlands D.; Fry E. E.; Rao Z.; Stuart D. I. More-Powerful Virus Inhibitors from Structure-Based Analysis of HEV71 Capsid-Binding Molecules. Nat. Struct. Mol. Biol. 2014, 21, 282–288. 10.1038/nsmb.2769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2769</ArticleId><ArticleId IdType="pmc">PMC4530014</ArticleId><ArticleId IdType="pubmed">24509833</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Q.; Zhu R.; Xu L.; He M.; Yan X.; Liu D.; Yin Z.; Wu Y.; Li Y.; Yang L.; Hou W.; Li S.; Li Z.; Chen Z.; Li Z.; Yu H.; Gu Y.; Zhang J.; Baker T. S.; Zhou Z. H.; Graham B. S.; Cheng T.; Li S.; Xia N. Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralization. Nat. Microbiol. 2019, 4 (1), 124–133. 10.1038/s41564-018-0275-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0275-7</ArticleId><ArticleId IdType="pmc">PMC6727974</ArticleId><ArticleId IdType="pubmed">30397341</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao T.; Li Y.; Fan S.; Li W.; Wang S.; Li S.; Cao R.; Zhong W. Design, Synthesis and Pharmacological Evaluation of a Novel mTOR-targeted Anti-EV71 Agent. Eur. J. Med. Chem. 2019, 175, 172–186. 10.1016/j.ejmech.2019.04.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2019.04.048</ArticleId><ArticleId IdType="pubmed">31082764</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L.; Yan Y.; Dai Q.; Li X.; Xu K.; Zou G.; Yang K.; Li W.; Guo X.; Yang J.; Li Y.; Xia Q.; Cao R.; Zhong W. Development of Novel Anti-influenza Thiazolides with Relatively Broad-Spectrum Antiviral Potentials. Antimicrob. Agents Chemother. 2020, 64, e00222.10.1128/AAC.00222-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00222-20</ArticleId><ArticleId IdType="pmc">PMC7318005</ArticleId><ArticleId IdType="pubmed">32312780</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J.; Xu Y.; Yan Y.; Li W.; Zhao L.; Dai Q.; Li Y.; Li S.; Zhong J.; Cao R.; Zhong W. Small Molecule Inhibitor of ATPase Activity of HSP70 as a Broad-Spectrum Inhibitor against Flavivirus Infections. ACS Infect. Dis. 2020, 6, 832–843. 10.1021/acsinfecdis.9b00376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.9b00376</ArticleId><ArticleId IdType="pubmed">31967789</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>